tiprankstipranks
Recordati Industria Chimica e Farmaceutica SPA (DE:RER1)
BERLIN:RER1

Recordati Industria Chimica e Farmaceutica SPA (RER1) Financial Statements

1 Followers

Recordati Industria Chimica e Farmaceutica SPA Financial Overview

Recordati Industria Chimica e Farmaceutica SPA's market cap is currently ―. The company's EPS TTM is €; its P/E ratio is ―; and it has a dividend yield of 2.21%. Recordati Industria Chimica e Farmaceutica SPA is scheduled to report earnings on May 9, 2024, and the estimated EPS forecast is €―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 22Sep 22Jun 22Mar 22Dec 21
Income Statement-
Total Revenue€ 475.76M€ 485.05M€ 473.11M€ 419.38M€ 423.88M
Gross Profit€ 331.83M€ 330.13M€ 320.71M€ 303.90M€ 309.16M
EBIT€ 103.60M€ 123.04M€ 78.46M€ 128.49M€ 116.84M
EBITDA€ 139.12M€ 156.10M€ 111.00M€ 153.14M€ 141.53M
Net Income Common Stockholders€ 70.88M€ 90.05M€ 54.69M€ 96.72M€ 89.58M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments€ 284.73M€ 346.61M€ 373.76M€ 261.43M€ 244.58M
Total Assets€ 4.00B€ 3.98B€ 3.98B€ 3.64B€ 2.82B
Total Debt€ 1.72B€ 1.70B€ 1.83B€ 1.67B€ 992.19M
Net Debt€ 1.43B€ 1.35B€ 1.45B€ 1.41B€ 747.61M
Total Liabilities€ 2.45B€ 2.37B€ 2.49B€ 2.19B€ 1.43B
Stockholders Equity€ 1.55B€ 1.61B€ 1.49B€ 1.45B€ 1.38B
Cash Flow-
Free Cash Flow€ 87.34M€ 114.12M€ 66.06M€ 97.83M€ 112.89M
Operating Cash Flow€ 100.00M€ 135.58M€ 112.68M€ 113.43M€ 123.51M
Investing Cash Flow€ -30.74M€ -21.27M€ 7.16M€ -722.27M€ -10.61M
Financing Cash Flow€ -111.16M€ -149.14M€ 30.14M€ 571.44M€ -212.25M
Currency in EUR

Recordati Industria Chimica e Farmaceutica SPA Earnings and Revenue History

Recordati Industria Chimica e Farmaceutica SPA Debt to Assets

Recordati Industria Chimica e Farmaceutica SPA Cash Flow

Recordati Industria Chimica e Farmaceutica SPA Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis